[
  {
    "ts": "2026-01-22T16:01:07+00:00",
    "headline": "Stock Market Today: Dow Up On GDP; Amgen Jumps To New Highs, As Abbott Gets Crushed (Live Coverage)",
    "summary": "The Dow Jones index rose Thursday on surprise GDP data. Nvidia and Tesla rallied in morning trading.",
    "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-sp500-nasdaq-inflation-data-nvidia-stock-tesla-tsla-stock/?src=A00220&yptr=yahoo",
    "source": "Investor's Business Daily",
    "provider": "yfinance",
    "raw": {
      "id": "fbaade7b-d55b-3626-b114-f84604de7c82",
      "content": {
        "id": "fbaade7b-d55b-3626-b114-f84604de7c82",
        "contentType": "STORY",
        "title": "Stock Market Today: Dow Up On GDP; Amgen Jumps To New Highs, As Abbott Gets Crushed (Live Coverage)",
        "description": "",
        "summary": "The Dow Jones index rose Thursday on surprise GDP data. Nvidia and Tesla rallied in morning trading.",
        "pubDate": "2026-01-22T16:01:07Z",
        "displayTime": "2026-01-22T16:01:07Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/fbaade7b-d55b-3626-b114-f84604de7c82/stock-market-today-dow-up-on.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/ibd.com/f0c9b86e1d3e55868d65f913087e5294",
          "originalWidth": 1000,
          "originalHeight": 563,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/SmwDqs68xLGqsSxDunUoYQ--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/f0c9b86e1d3e55868d65f913087e5294.cf.webp",
              "width": 1000,
              "height": 563,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/1qemVk8ONwuEP3_bn4n7Wg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/f0c9b86e1d3e55868d65f913087e5294.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Investor's Business Daily",
          "url": "http://www.investors.com/"
        },
        "canonicalUrl": {
          "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-sp500-nasdaq-inflation-data-nvidia-stock-tesla-tsla-stock/?src=A00220&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AMGN"
            },
            {
              "symbol": "META"
            },
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "^IXIC"
            },
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "TSLA"
            },
            {
              "symbol": "SI=F"
            },
            {
              "symbol": "BTC-USD"
            },
            {
              "symbol": "GC=F"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-22T23:11:30+00:00",
    "headline": "Amgen (AMGN) Faces 340B Lawsuit: What Does Sagebrush Dispute Reveal About Its Stakeholder Strategy?",
    "summary": "Sagebrush Health Services has filed a lawsuit in California state court accusing Amgen of unlawfully cutting off 340B discounted drug sales to its Nevada clinics and reclaiming at least US$7,000,000 in past discounts, allegedly disrupting care for low-income and uninsured patients. The case highlights growing legal and reputational risks around how drug makers interact with 340B “covered entities,” and whether manufacturers can effectively police program eligibility outside the federal...",
    "url": "https://finance.yahoo.com/news/amgen-amgn-faces-340b-lawsuit-231130667.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "c8595d68-f3ac-3932-af40-27505f2ebb09",
      "content": {
        "id": "c8595d68-f3ac-3932-af40-27505f2ebb09",
        "contentType": "STORY",
        "title": "Amgen (AMGN) Faces 340B Lawsuit: What Does Sagebrush Dispute Reveal About Its Stakeholder Strategy?",
        "description": "",
        "summary": "Sagebrush Health Services has filed a lawsuit in California state court accusing Amgen of unlawfully cutting off 340B discounted drug sales to its Nevada clinics and reclaiming at least US$7,000,000 in past discounts, allegedly disrupting care for low-income and uninsured patients. The case highlights growing legal and reputational risks around how drug makers interact with 340B “covered entities,” and whether manufacturers can effectively police program eligibility outside the federal...",
        "pubDate": "2026-01-22T23:11:30Z",
        "displayTime": "2026-01-22T23:11:30Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/8ab44b8ef28c7f69299492d5b9c5a46c",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ACuIXYrNeojUXbAJFhnPIg--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/8ab44b8ef28c7f69299492d5b9c5a46c.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/B7CQJIEa.2c0sQ0XIU66pg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/8ab44b8ef28c7f69299492d5b9c5a46c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/amgen-amgn-faces-340b-lawsuit-231130667.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/amgen-amgn-faces-340b-lawsuit-231130667.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AMGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-22T23:00:02+00:00",
    "headline": "Amgen (AMGN) Outpaces Stock Market Gains: What You Should Know",
    "summary": "Amgen (AMGN) reached $347.07 at the closing of the latest trading day, reflecting a +1.01% change compared to its last close.",
    "url": "https://finance.yahoo.com/news/amgen-amgn-outpaces-stock-market-230002703.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "65490ea5-c2c3-3979-b8b7-ee13c337f3a2",
      "content": {
        "id": "65490ea5-c2c3-3979-b8b7-ee13c337f3a2",
        "contentType": "STORY",
        "title": "Amgen (AMGN) Outpaces Stock Market Gains: What You Should Know",
        "description": "",
        "summary": "Amgen (AMGN) reached $347.07 at the closing of the latest trading day, reflecting a +1.01% change compared to its last close.",
        "pubDate": "2026-01-22T23:00:02Z",
        "displayTime": "2026-01-22T23:00:02Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/3cb5117fc22f5e37890d1860dcd61f9f",
          "originalWidth": 900,
          "originalHeight": 675,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/SVlgtyKcqJmTvHzvwqjZfA--~B/aD02NzU7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/3cb5117fc22f5e37890d1860dcd61f9f.cf.webp",
              "width": 900,
              "height": 675,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/7KqPU5XU5bEHAxdnZQ3L5g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/3cb5117fc22f5e37890d1860dcd61f9f.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/amgen-amgn-outpaces-stock-market-230002703.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/amgen-amgn-outpaces-stock-market-230002703.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AMGN"
            },
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "^IXIC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]